Endo Pharmaceuticals Solutions

Endo is a specialty pharmaceutical company focused on developing and delivering high-value medicines and clinical solutions. The company operates through several segments, including Branded Pharmaceuticals, Sterile Injectables, and Generic Pharmaceuticals. Its portfolio features well-known products such as Xiaflex for Dupuytren's contracture and Peyronie's disease, as well as a robust line of sterile injectable products like Vasostrict. Following a financial restructuring in 2024, the company emerged as Endo, Inc., continuing its focus on specialty therapeutic areas including urology, orthopedics, and medical aesthetics.